BranchLab Raises $26 Million Series A Led by McKesson Ventures
BranchLab has raised $26 million in Series A funding led by McKesson Ventures, with participation from FCA Venture Partners, Sanofi Ventures, and AIX Ventures, announced in a press release. The round brings the company’s total funding to $35 million.
BranchLab provides an AI platform that helps pharmaceutical companies identify, segment, and activate patient and healthcare professional audiences. The platform enables teams to act on aggregated, privacy-safe data in near real time, improving marketing efficiency and reducing reliance on manual processes.
At the core of BranchLab’s system is a transformer-based architecture that trains models within customer-controlled environments. Only non-sensitive demographic and media data are deployed, allowing faster and compliant activation of campaigns. The company reports that its platform has delivered an average 70% improvement in marketing efficacy across multiple therapeutic areas.
With the new funding, BranchLab plans to expand enterprise deployments, strengthen integrations across healthcare and media systems, and continue developing its unified AI platform for pharmaceutical commercialization.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly, AI Funding Brief or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 19 Knit Health raises $35 million to roll out its healthcare world model Nov 19 Banner Health invests in Layer Health and moves its clinical registries onto its AI platform Nov 19 Half of Koreans who changed medication on AI advice had side effects, survey finds Nov 19 Isomorphic Labs and MSD team up to design cancer drugs with AI Nov 19 Boltz raises $110 million to build AI models for drug designMore from Funding
Nov 20 Archer, formerly hackajob, raises $10 million for its AI recruiting platform Nov 20 Protesters rally against Anthropic in New York and San Francisco on its stock market debut Nov 19 Anthropic's IPO could channel about $156 billion to charity, TechCrunch estimates Nov 19 Sierra reportedly in talks to raise at a $30 billion valuation Nov 19 Everful raises $48.5 million to build AI infrastructure for global commerceAI Funding Brief
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Atlas Bio raises $12.5 million for virtual drug trials
London's Model ML raises $250M at a $1.5B valuation for AI agents for bankers and consultants
Broccoli Raises $52 Million for Home Service AI Agents
Zus Health raises $33 million to build the data layer for healthcare AI
Crux Labs raises more than $6 million to audit AI agents
Daily AI Brief: the AI news that matters, in your inbox.